Dunvegan Associates’s Allergan plc AGN Stock Holding History

Dunvegan Associates’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$2.63M	Sell	8,407 -152	-2%	-$45.3K	3.09%	10
2015 Q3	$2.33M	Sell	8,559 -138	-2%	-$42.4K	2.65%	11
2015 Q2	$2.64M	Sell	8,697 -1,775	-17%	-$529K	2.92%	9
2015 Q1	$3.12M	Sell	10,472 -18,553	-64%	-$5.29M	2.76%	10
2014 Q4	$6.17M	Sell	29,025 -958	-3%	-$239K	5.36%	4
2014 Q3	$5.34M	Sell	29,983 -165	-0.5%	-$36.9K	4.83%	7
2014 Q2	$5.1M	Sell	30,148 -210	-0.7%	-$43.5K	4.26%	8
2014 Q1	$3.77M	Buy	+30,358	New	+$6.01M	3.17%	9

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Dunvegan Associates's AGN Position: Q4 2015 in Review

Dunvegan Associates reduced its Allergan plc (AGN) stake by 1.8% in Q4 2015, selling an estimated $45.3K and leaving 8,407 shares worth $2.63M. The position accounts for 3.09% of the portfolio, ranked #10.

Dunvegan Associates first reported a position in AGN in Q1 2014 and has held it in 8 quarters since. The position peaked at $6.17M in Q4 2014. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Dunvegan Associates held 8,407 shares of Allergan plc worth $2.63M as of Q4 2015.
Dunvegan Associates sold 152 Allergan plc shares in Q4 2015, an estimated $45.3K.
Allergan plc made up 3.09% of Dunvegan Associates's portfolio in Q4 2015, its #10 holding.
Dunvegan Associates first reported a position in Allergan plc in Q1 2014 and has held it in 8 quarters since.
Dunvegan Associates's Allergan plc position peaked at $6.17M in Q4 2014.
1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.